GANT-61 (GLI1/2 inhibitor) can inhibit tumor cell proliferation and block tumor growth in ARMS and ERMS animal models by inhibiting the Shh/AKT–mTOR signaling axis (20). Here, AKT1 is linked to neoplasm.